"Official medicines" is the best online drugstore.

World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system.

The meds you need, reliable and hassle free! Top products of top brands.

The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe!

(Ezz-ET-ih-mibe)
Zetia
Tablets: 10 mg
Class: Antihyperlipidemic

 Action Inhibits absorption of cholesterol by the small intestine.

Absorption: Cmax is 3.4 to 5.5 ng/mL (ezetimibe) and 45 to 71 ng/mL (metabolite). Tmax is 4 to 12 hr (ezetimibe) and 1 to 2 hr (metabolite).

Distribution: More than 90% protein bound.

Metabolism: Metabolized (active) in small intestine and liver to ezetimibe glucoronide.

Elimination: The t½ is approximately 22 hr. Approximately 78% is excreted in feces and 11% in urine.

Elderly: Plasma concentrations are approximately 2-fold higher.

Hepatic function impairment: AUC increased approximately 1.7-fold in those with mild insufficiency, 3- to 4-fold in moderate insufficiency and 5- to 6-fold in severe impairment.

Renal function impairment: AUC increased approximately 1.5-fold in those with severe renal disease (Ccr up to 30 mL/min).

 Indications Administration alone or with HMG-CoA reductase inhibitors as adjunctive therapy to diet for reduction of elevated total cholesterol, low density lipoprotein cholesterol (LDL), and apolipoprotein in patients with primary hypercholesterolemia; with atorvastatin or simvastatin for the reduction of elevated total cholesterol and LDL levels in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatments or if such treatments are unavailable; as adjunctive therapy to diet for the reduction of elevated sitosterol and campesterol levels in patients with homozygous familial sitosterolemia.

 Contraindications Ezetimibe is contraindicated in combination with HMG-CoA reductase inhibitors in patients with active liver disease or unexplained persistent elevations in serum transaminases; hypersensitivity to any component of the product.

 Route/Dosage

Adults and children over 10 yr: PO 10 mg once daily.

 Interactions

Antacids: Aluminum- and magnesium-containing antacids decrease the peak concentration of ezetimibe but not the AUC. Cholestyramine: The AUC of ezetimibe may be decreased. Cyclosporine, fibric acid derivatives (eg, fenofibrate, gemfibrozil): Concentrations of ezetimibe may be increased.

 Lab Test Interferences None well documented.

 Adverse Reactions

CNS: Fatigue; headache; dizziness. EENT: Sinusitis; pharyngitis. GI: Diarrhea; abdominal pain. RESPIRATORY: Coughing; upper respiratory tract infection. OTHER: Back pain; arthralgia; viral infection; myalgia; chest pain.

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established in children under 10 yr. Secondary causes of hyperlipidemia: Ruled out or treat secondary causes of hyperlipidemia before starting treatment with ezetimibe. Hepatic impairment: Use not recommended because of unknown effects on liver.

PATIENT CARE CONSIDERATIONS

 Administration/Storage

  • Give prescribed dose once daily with or without food.
  • Administer alone or in combination with other lipid-lowering therapy.
  • May be administered at the same time as an HMG-CoA reductase inhibitor.
  • Administer 2 hr before or 4 hr after a bile acid sequestrant.
  • Store tablets at controlled room temperature (59° to 86°F). Protect from moisture.

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note presence of active liver disease or moderate to severe hepatic insufficiency.
  • Ensure that patient is on a cholesterol-lowering diet.
  • Ensure that lipids are measured before therapy is started and periodically during therapy.
  • Assess patient for GI, musculoskeletal, respiratory, and general body side effects. If noted and significant, inform health care provider.

 Patient/Family Education

  • Explain name, dose, action, and potential side effects of drug.
  • Advise patient to review “Patient Information about Zetia
    ” before starting the medication and each time when refilling the medication.

  • Advise patient to take once daily as prescribed, without regard to meals.
  • Advise patient to try to take each dose at about the same time each day.
  • Inform patient that drug helps control, but not does cure, cholesterol abnormality and to continue taking drug as prescribed if cholesterol levels are lowered.
  • Caution patient not to change the dose or stop taking unless advised by health care provider.
  • Advise patient that if a dose is missed to take as soon as remembered but to never take more than 1 dose of medicine a day.
  • Instruct patient to continue taking other cholesterol-lowering medications as prescribed by health care provider.
  • Emphasize to patient importance of the following other modalities on cholesterol control: dietary changes (eg, reduced saturated fat intake, increase soluble fiber intake); weight control, regular exercise, and smoking cessation.
  • Advise women to contact health care provider if pregnant, planning to become pregnant, or breastfeeding.
  • Caution patient to not take any prescription or OTC medications or dietary supplements unless advised by health care provider.
  • Instruct patient to notify health care provider if experiencing any unexplained muscle pain, tenderness, or weakness or noting any other unusual feelings.
  • Advise patient that follow-up visits and lab tests will be required to monitor therapy and to keep appointments.

Popularity: 2% [?]


If you're still unable to find appropriate information in the article, please use search form below